FP
IART icon

Foundry Partners’s Integra LifeSciences IART Stock Holding History

Foundry Partners’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-55,922
Closed -$3.1M – 395
2018
Q1 		$3.1M Sell
55,922
-70
-0.1% -$3.67K 0.13% 235
2017
Q4 		$2.68M Sell
55,992
-532
-0.9% -$26K 0.11% 238
2017
Q3 		$2.85M Sell
56,524
-98
-0.2% -$5.03K 0.11% 272
2017
Q2 		$3.09M Buy
56,622
+3,662
+7% +$175K 0.13% 264
2017
Q1 		$2.23M Buy
52,960
+8,716
+20% +$372K 0.09% 305
2016
Q4 		$1.9M Hold
44,244
– – 0.08% 315
2016
Q3 		$1.83M Buy
44,244
+988
+2% +$41.4K 0.1% 269
2016
Q2 		$1.73M Buy
+43,256
New +$1.56M 0.1% 276

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Foundry Partners's IART Position: Q2 2018 in Review

Foundry Partners sold out of Integra LifeSciences (IART) in Q2 2018, closing a stake of 55,922 shares — an estimated $3.1M sold.

Foundry Partners first reported a position in IART in Q2 2016 and held it in 8 quarters. The position peaked at $3.1M in Q1 2018. 257 funds tracked by Wall St. Rank hold IART as of Q2 2018.

  • Foundry Partners reported no remaining Integra LifeSciences position as of Q2 2018 after selling out during the quarter.
  • Foundry Partners sold 55,922 Integra LifeSciences shares in Q2 2018, an estimated $3.1M.
  • Foundry Partners first reported a position in Integra LifeSciences in Q2 2016 and held it in 8 quarters.
  • Foundry Partners's Integra LifeSciences position peaked at $3.1M in Q1 2018.
  • 257 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2018.

Based on Foundry Partners's 13F filing for Q2 2018, filed 19 Jul 2018.